Eagle Pharmaceuticals Market Cap

Eagle Pharmaceuticals has a market cap or net worth of $19.40 million as of February 21, 2025. Its market cap has decreased by -73.32% in one year.

Market Cap

19.40M

Enterprise Value

n/a

Revenue

257.55M

Ranking

n/a

PE Ratio

1.63

Stock Price

$1.49

Market Cap Chart

Since February 12, 2014, Eagle Pharmaceuticals's market cap has decreased from 39.11M to 19.40M, a decrease of -50.38%. That is a compound annual growth rate of -6.15%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	19.40M	198.00%
Dec 31, 2024	6.51M	-90.41%
Dec 29, 2023	67.92M	-82.15%
Dec 30, 2022	380.45M	-42.14%
Dec 31, 2021	657.57M	8.37%
Dec 31, 2020	606.81M	-26.12%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.19B
SS Innovations International	1.72B
Nika Pharmaceuticals	1.02B
Veradigm	864.81M
Elite Pharmaceuticals	520.73M
Glass House Brands	497.07M
CytoDyn	367.12M
Northwest Biotherapeutics	326.95M

Market Cap Rankings